
Recent Advances of Type I Interferon on the Regulation of Immune Cells and the Treatment of Systemic Lupus Erythematosus
Introduction Systemic lupus erythematosus (SLE) is a persistent, incapacitating, diverse autoimmune condition distinguished by type I interferons (IFN-I), circulating antinuclear antibodies (such as dsDNA and snRNP), and immune complex deposition, leading …